The global clinical risk grouping market is projected to grow with a CAGR of nearly 14% over the forecast period. The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care. Besides, accuracy in risk assessment and growing investments in R&D of new therapeutics is anticipated to boost the market growth over the forecast period. Furthermore, the compilation of patient information in a healthcare setting, resulting in physician burden, increases the demand for clinical risk grouping solutions.
However, lack of skilled professionals, concerns regarding the private cloud data management, and high costs related to management solutions are projected to hamper the market growth over the forecast period.
Key Market Trends
Dashboard and Data Visualisation Tools are Anticipated to Grow at Significant Rate
Dashboard and data visualization tools are anticipated to grow at notable rates owing to its ability to predict the payment process and predict payment risk. Besides, increasing the need to reduce healthcare costs coupled with the increasing adoption of big data is anticipated to boost the market growth over the forecast period. Moreover, the adoption of cloud-based technologies to manage clinical data and the growing prevalence of chronic diseases is expected to fuel market growth.
The hospital segment is anticipated to have notable market growth owing to increasing adoption of big data, growing focus of caregivers in risk management solution, increasing investment in infrastructure to enhance the healthcare facilities to improve the care.
North America Expected to Have Significant Market Growth
Among the regional segment, North America is expected to have significant market growth over the forecast period. This growth is attributed to the growing prevalence of chronic diseases, well-established healthcare infrastructure, and the high adoption of advanced technologies and government initiatives to mandate health records maintenance.
However, the Asia Pacific region is projected to have lucrative market growth opportunities due to the presence of a large pool of patient populations, increasing need for better risk management solutions, adoption of recording and maintaining the health records, and growing prevalence of chronic diseases.
The global clinical risk grouping market is moderately consolidated and competitive. Market players are focusing on new product launches, product innovations, and geographical expansion. F. The key market players operating in the market include 3M Company, Optum Inc., Conduent Inc., Lightbeam Health Solutions, and Health Catalyst.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support